ES2105971B1 - ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. - Google Patents

ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Info

Publication number
ES2105971B1
ES2105971B1 ES9501567A ES9501567A ES2105971B1 ES 2105971 B1 ES2105971 B1 ES 2105971B1 ES 9501567 A ES9501567 A ES 9501567A ES 9501567 A ES9501567 A ES 9501567A ES 2105971 B1 ES2105971 B1 ES 2105971B1
Authority
ES
Spain
Prior art keywords
hydroxybenzoate
antibiotic
inflammatory composition
polyethylene glycol
otic application
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES9501567A
Other languages
Spanish (es)
Other versions
ES2105971A1 (en
Inventor
Carreras Manuel Roig
Vidal Carlos Montserrat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Salvat SA
Original Assignee
Laboratorios Salvat SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Salvat SA filed Critical Laboratorios Salvat SA
Priority to ES9501567A priority Critical patent/ES2105971B1/en
Publication of ES2105971A1 publication Critical patent/ES2105971A1/en
Application granted granted Critical
Publication of ES2105971B1 publication Critical patent/ES2105971B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

COMPOSICION ANTIBIOTICA/ANTIINFLAMATORIA DE APLICACION OTICA COMPRENDE: 0.1-0.4 G DE CIPROFLOXACINO, 0.2-1.5 G DE HIDROCORTISONA, 0.3-0.8 G DE ACIDO LACTICO AL 20%; 0.3-0.6 G DE ACIDO CLORHIDRICO 1M, 1-3 G DE GLUCOSA, 1-3 G DE UN VISCOSIZANTE (PREFERIBLEMENTE POLIVINILPIRROLIDONA), 30-60 G DE UN CODISOLVENTE (PREFERIBLEMENTE PROPILENGLICOL O POLIETILENGLICOL), 1-3 G DE POLISORBATO POLIOXIETILENADO, Y 0.01-0.08 G DE UN AGENTE CONSERVANTE ELEGIDO ENTRE P-HIDROXIBENZOATO DE METILO, P-HIDROXIBENZOATO DE ETILO Y P-HIDROXIBENZOATO DE PROPILO. TIENE UTILIDAD PARA EL TRATAMIENTO TOPICO DE LA OTITIS, ESPECIALMENTE DE LA OTITIS MEDIA ACOMPAÑADA DE PROCESO INFLAMATORIO GENERAL. CONLLEVA LA VENTAJA DE QUE SE PUEDE APLICAR A NIÑOS, Y DE QUE NO PRESENTA EL RIESGO DE OTOTOXICIDAD EN CASOS DE PERFORACION DEL TIMPANO, ASOCIADO A OTRAS COMBINACIONES DE ANTIBIOTICOS Y ANTIINFLAMATORIOS QUE SE USAN POR VIA TOPICA.ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION INCLUDES: 0.1-0.4 G OF CIPROFLOXACINO, 0.2-1.5 G OF HYDROCORTISONE, 0.3-0.8 G OF LACTIC ACID AT 20%; 0.3-0.6 G OF HYDROCHLORIC ACID 1M, 1-3 G OF GLUCOSE, 1-3 G OF A VISCOSIZANT (PREFERABLY POLYVINYLPYROLIDONE), 30-60 G OF A CO-SOLVENT (PREFERABLY PROPYLENE GLYCOL, POLYETHYLENE GLYCOL), 1-3 G OF POLYETHYLENE GLYCOL, AND 0.01-0.08 G OF A PRESERVING AGENT CHOSEN BETWEEN METHYL P-HYDROXYBENZOATE, ETHYL P-HYDROXYBENZOATE AND PROPYL P-HYDROXYBENZOATE. IT IS USEFUL FOR THE TOPICAL TREATMENT OF OTITIS, ESPECIALLY OF OTITIS MEDIA ACCOMPANIED BY A GENERAL INFLAMMATORY PROCESS. IT HAS THE ADVANTAGE THAT IT CAN BE APPLIED TO CHILDREN, AND THAT IT DOES NOT PRESENT THE RISK OF OTOTOXICITY IN CASES OF PERFORATION OF TIMPANO, ASSOCIATED WITH OTHER COMBINATIONS OF ANTIBIOTICS AND ANTI-INFLAMMATORIES USED BY VIA TOPICA.

ES9501567A 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION. Expired - Lifetime ES2105971B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9501567A ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9501567A ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Publications (2)

Publication Number Publication Date
ES2105971A1 ES2105971A1 (en) 1997-10-16
ES2105971B1 true ES2105971B1 (en) 1998-07-01

Family

ID=8291261

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9501567A Expired - Lifetime ES2105971B1 (en) 1995-08-02 1995-08-02 ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.

Country Status (1)

Country Link
ES (1) ES2105971B1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160090B1 (en) * 2000-03-16 2002-07-01 Vita Invest Sa Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration
ES2171147B1 (en) * 2001-02-06 2003-12-16 Esteve Labor Dr PREPARATION FOR VETERINARY USES.
ES2245611B1 (en) * 2004-06-29 2007-03-16 Laboratorio Reig Jofre, S.A. PHARMACEUTICAL COMPOSITION FOR OTOTOPIC USE.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704907A1 (en) * 1987-02-17 1988-08-25 Bayer Ag TOPICALLY APPLICABLE PREPARATIONS OF GYRASE INHIBITORS IN COMBINATION WITH CORTICOSTEROIDS
AU4201189A (en) * 1988-08-26 1990-03-23 Alcon Laboratories, Inc. Combination of quinolone antibiotics and steroids for topical ophthalmic use
ES2065846B1 (en) * 1993-04-20 1995-10-01 Cusi Lab PHARMACEUTICAL FORMULATION BASED ON A STEROID OR NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTIBIOTIC BELONGING TO THE GIRASE DNA INHIBITORS GROUP FOR ITS TOPICAL OPHTHALMIC USE.

Also Published As

Publication number Publication date
ES2105971A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
BR9714287A (en) Crystalline antibiotic called 6-o-metilerithromycin solvate form 0, 6-o-metilerithromycin solvate form 0, composition, processes for treating bacterial infections in a host mammal in need of such treatment and for the preparation of 6-o-metilerithomycin solvate the 0, 6-o-metilerithromycin form 0 - ethanolate, suspension for oral administration, and the 6-o-metilerithromycin solvate complex the 0-carbomer form.
BRPI9913945B8 (en) Rapidly acting pharmaceutical composition for the sublingual administration of a pharmaceutical agent for the treatment of acute disorders
ES2079994B1 (en) PHARMACEUTICAL FORMULATION BASED ON POLYMIXINE-TRIMETOPRIM AND AN ANTI-INFLAMMATORY AGENT FOR ITS TOPICAL OPHTHALMIC AND ETHICAL USE.
BR9801008A (en) Aerosol formulation suitable for therapy, prophylaxis or containment of mycobacterium tuberculosis infections in a patient suffering from tuberculosis
NZ333380A (en) 6-O-methylerythromycin A crystal form I (clarithromycin) and preparation thereof
ES2094906T3 (en) COMPOSITIONS FOR THE TOPIC ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS.
RS49721B (en) Composition containing herb and surfaction useful in production of products for treatmen of herpes and other microbial infections
CO5160320A1 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION OF TOLERANCE TO MEDICINES DAS.
ES2154287T3 (en) PROCEDURE TO MODIFY THE GROWTH OF HAIRS AND / OR HAIRS AND COMPOSITIONS USED FOR THIS EFFECT.
AR010995A1 (en) USE OF MUPIROCINA, SALTS OR ESTERS OF THE SAME IN OBTAINING ADMINISTRABLE MEDICINES VIA NASAL AND PHARMACEUTICAL FORMULATIONS INCLUDING ADMINISTRABLE PHARMACEUTICAL FORMULATIONS VIA NASAL.
BR9805993A (en) Aerosol pharmaceutical composition.
CA2254079A1 (en) Androstene derivatives
BR9709097A (en) Pharmaceutical composition for the treatment of diseases mediated by cyclooxygenase process to treat an inflammatory disease susceptible to treatment with an anti-inflammatory agent in the steroid use and oral form of unit dose
NO934706L (en) Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines
DK0900233T3 (en) Steroid nitrite and nitrate ester derivatives which can be used as anti-inflammatory drugs
NO980317L (en) Use of Calendula glycosides for the treatment of psoriasis
ES2105971B1 (en) ANTIBIOTIC / ANTI-INFLAMMATORY COMPOSITION OF OTIC APPLICATION.
AU563831B2 (en) N-(2-amino-3,5-dibromobenzyl)- trans-4-amino-cyclohexanol derivatives
AU1277397A (en) Steroid nitrite ester derivatives useful as anti-inflammatory drugs
ES2088742B1 (en) ANTIBIOTIC COMPOSITION OF OTIC APPLICATION.
NO964915L (en) Transdermal delivery of antiepileptic drugs
ATE173396T1 (en) SPRAY FORMULATION WITH COOLING EFFECT
PT90085A (en) METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING A GOLD ORGANIC COMPLEX FOR TOPIC APPLICATION
AU545885B2 (en) Oral absorption of glycosidic antibiotics
ES2061666T3 (en) CRYSTALLINE ANTIBIOTIC INTERMEDIATE.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19971016

Kind code of ref document: A1

Effective date: 19971016